HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yi-Chin Lin Selected Research

Peptidylprolyl Isomerase (Prolyl Isomerase)

3/2011A dual inhibitor against prolyl isomerase Pin1 and cyclophilin discovered by a novel real-time fluorescence detection method.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yi-Chin Lin Research Topics

Disease

6Neoplasms (Cancer)
01/2022 - 03/2011
4Inflammation (Inflammations)
01/2017 - 12/2007
4Coronary Artery Disease (Coronary Atherosclerosis)
06/2016 - 01/2012
2Body Weight (Weight, Body)
11/2018 - 01/2007
2Insulin Resistance
01/2018 - 05/2015
2Neuroblastoma
04/2008 - 12/2007
1Prostatic Neoplasms (Prostate Cancer)
01/2022
1Neoplasm Metastasis (Metastasis)
01/2022
1Bundle-Branch Block (Fascicular Block)
12/2019
1Osteoporosis
11/2018
1Heart Failure
11/2018
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/2018
1Atrophy
02/2018
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Neuroinflammatory Diseases
01/2017
1Seizures (Absence Seizure)
01/2017
1Lung Neoplasms (Lung Cancer)
02/2016
1Carcinoma (Carcinomatosis)
02/2016
1Contact Dermatitis (Eczema, Contact)
05/2014
1Communicable Diseases (Infectious Diseases)
03/2011
1Alzheimer Disease (Alzheimer's Disease)
03/2011
1Chronic Obstructive Pulmonary Disease (COPD)
01/2010
1Neurodegenerative Diseases (Neurodegenerative Disease)
04/2008
1Acquired Immunodeficiency Syndrome (AIDS)
04/2008
1Intracranial Vasospasm
12/2007
1Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
12/2007

Drug/Important Bio-Agent (IBA)

6AntioxidantsIBA
01/2018 - 01/2010
4EnzymesIBA
01/2018 - 01/2012
3QuercetinIBA
06/2021 - 01/2014
3coenzyme Q10 (CoQ10)IBA
11/2018 - 01/2012
3LipidsIBA
01/2018 - 05/2015
3Carnitine (L-Carnitine)FDA LinkGeneric
06/2016 - 08/2014
2ubiquinolIBA
11/2018 - 01/2018
2trichostatin A (A 300)IBA
02/2018 - 02/2016
2Proteins (Proteins, Gene)FDA Link
02/2018 - 02/2016
2theasinensin AIBA
02/2018 - 02/2016
2LipopolysaccharidesIBA
01/2017 - 04/2008
2Phosphotransferases (Kinase)IBA
01/2017 - 05/2015
2Oxidopamine (6 Hydroxydopamine)IBA
04/2008 - 12/2007
1Plasminogen Activator Inhibitor 1IBA
01/2022
1Serine Proteases (Serine Protease)IBA
01/2022
1matriptase 2IBA
01/2022
1Remifentanil (Ultiva)FDA Link
12/2019
1CoffeeFDA Link
11/2018
1Myosin Heavy Chains (Myosin Heavy Chain)IBA
02/2018
13-hydroxyflavoneIBA
02/2018
1HDL CholesterolIBA
01/2018
1Insulin (Novolin)FDA Link
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1EverolimusFDA Link
01/2017
1MTOR InhibitorsIBA
01/2017
1Kainic Acid (Kainate)IBA
01/2017
1Sirolimus (Rapamycin)FDA Link
01/2017
1TOR Serine-Threonine KinasesIBA
01/2017
1GenisteinIBA
02/2016
1Histones (Histone)IBA
02/2016
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
02/2016
1Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2015
1Small Interfering RNA (siRNA)IBA
05/2015
1PalmitatesIBA
05/2015
1Malondialdehyde (Propanedial)IBA
03/2015
1C-Reactive ProteinIBA
03/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2015
1Inflammation MediatorsIBA
03/2015
1InterleukinsIBA
03/2015
1GoldIBA
05/2014
1Peptidylprolyl Isomerase (Prolyl Isomerase)IBA
03/2011
1VitaminsIBA
01/2010
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
01/2010
1Oxidants (Oxidizing Agents)IBA
01/2010
1beta Carotene (Betacarotene)FDA Link
01/2010
1Carotenoids (Carotene)IBA
01/2010
1Plant ExtractsIBA
04/2008
1catechol (pyrocatechol)IBA
04/2008
1N- (4- O- glycerol- 3- methoxybenzyl)nonivamideIBA
12/2007
1Calcitonin Gene-Related PeptideIBA
12/2007
1Neuroprotective AgentsIBA
12/2007
1TRPV Cation ChannelsIBA
12/2007
1NeurotoxinsIBA
12/2007
1Dietary PhosphorusIBA
01/2007

Therapy/Procedure

1Intraperitoneal Injections
06/2021
1Hemorrhoidectomy
12/2019
1Oral Administration
05/2014